Directorate Change

RNS Number : 5710U
Dechra Pharmaceuticals PLC
08 April 2016
 

 

Friday, 8 April 2016

 

Dechra® Pharmaceuticals PLC

(Dechra, Company or the Group)

Board Changes

 

Appointment of Chairman

Dechra is pleased to announce that Tony Rice has been appointed to the Board as Non-Executive Director and will be appointed as Chairman with effect from the conclusion of the Company's Annual General Meeting on 21 October 2016 ("the AGM"), subject to his election as a Director of the Company at the AGM.  As previously outlined to shareholders, Mike Redmond will step down from the Board at the conclusion of the AGM.

 

This appointment follows a comprehensive search process which was led by Ishbel Macpherson, Senior Independent Director, on behalf of the Board and which was undertaken by an external search agency.

 

Tony Rice has extensive board level experience across a range of sectors. He is currently the Senior Independent Non-Executive Director and Chair of the Remuneration Committee at Halma plc, having previously served as Chief Executive Officer at Cable & Wireless and Tunstall Holdings, and prior to that held various roles at BAE Systems including Managing Director of Commercial Aircraft and Group MD of Business Development.  Tony has also served as a non-executive director at Punch Taverns, Spirit Pub Company, Cable & Wireless, Telewest Communications and Saab Technologies, and Chairman of Alexander Mann Solutions.

 

Ian Page, Chief Executive Officer, Dechra Pharmaceuticals said:

"On behalf of the Board and all stakeholders, I welcome Tony to the business.  He has gained extensive knowledge of international businesses and has a solid understanding of key strategic drivers.  These skills will further enhance the team's capabilities. I would also like to acknowledge Mike's significant contribution to the development of the Group and his leadership of the Board over the past 15 years.  We wish him all the best for the future."

 

Mike Redmond, Dechra's Chairman added:

"Over my tenure I have witnessed Dechra grow from a UK-Services business into a global specialist veterinary pharmaceuticals group.  This solid international footprint today provides the foundation for the ongoing development of our business model.  Tony will bring a new perspective to the team and I am in no doubt that he will make a strong contribution to the delivery of our strategic goals into the future."

 

Tony Rice said:

"I am delighted to be joining Dechra to work with Ian, his management team and the Board to build on and continue the successful growth of the business to date."

 

There are no other disclosures to be made in respect of Tony Rice, pursuant to Listing Rule 9.6.13R.

 

Non-Executive Director Departure

After almost 6 years' service to the Company, Chris Richards has notified the Board of his intention to step down from his position as a Non-Executive Director of the Company with immediate effect. Chris will also stand down as the Chairman of the Remuneration Committee.

 

Ishbel Macpherson will succeed Chris Richards as Chairman of the Remuneration Committee.

 

Mike Redmond, Group Chairman, commented on Chris Richards' departure on behalf of the Board:

"Chris has made an outstanding contribution to the company as a Non-Executive Director and as Chairman of the Remuneration Committee, we are sorry to see him leave.  We wish him well for the future."

 

 

Enquiries to:

Dechra Pharmaceuticals PLC

Ian Page, Chief Executive Officer

Office:  +44 (0) 1606 814 730

e-mail: corporate.enquiries@dechra.com


TooleyStreet Communications Ltd

Fiona Tooley, Director

Mobile: +44 (0) 7785 703 523

e-mail: fiona@tooleystreet.com

 

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. 

 

For more information please visit: www.dechra.com

Stock Code: Full Listing (Pharmaceuticals): DPH

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALFFELSVIDIIR
UK 100

Latest directors dealings